Your session is about to expire
← Back to Search
Education and Monitoring for High Blood Pressure Control in HIV Patients
N/A
Recruiting
Led By Charles Muiruri, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aims 1A and 1B: Age ≥18 years, Confirmed HIV+ diagnosis, Undetectable HIV viral load, Hypertension diagnosis in medical records, Taking an antihypertensive medication, Receiving care at the Duke HIV clinic
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will identify and assess factors that impact hypertension medication adherence for PWH, in order to tailor an intervention to improve hypertension outcomes and reduce cardiovascular disease risk.
Who is the study for?
This trial is for adults over 18 with HIV who have achieved viral suppression and are being treated at the Duke ID clinic. They must have high blood pressure despite taking medication, as shown by their medical records. People can't join if they're severely hearing or speech impaired, in a nursing home, terminally ill, without phone access, pregnant or planning to be so soon, non-English speaking, or moving away within six months.Check my eligibility
What is being tested?
The study aims to improve blood pressure control among people living with HIV (PWH) on antiretroviral therapy (ART) to reduce heart disease risk. It will identify factors affecting hypertension medication adherence and test an educational and monitoring intervention tailored for PWH who've achieved viral suppression.See study design
What are the potential side effects?
Since the intervention focuses on education and monitoring rather than new medications, side effects are not a primary concern of this trial. However, participants may experience stress or anxiety related to increased focus on health management.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18, HIV positive with undetectable viral load, have hypertension, take blood pressure medicine, and receive care at the Duke HIV clinic.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of nurse managed adherence strategy
Feasibility as measured by enrollment
Subject's evaluation of ease of the completion of blood pressure logs
+2 moreSecondary outcome measures
Change in subject's self report of anti-hypertensive medication adherence
Body Weight Changes
Bronchial Provocation Tests
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Aim 3BExperimental Treatment1 Intervention
This aim will evaluate the feasibility and acceptability of the adapted health care delivery intervention to improve anti-hypertensive medication adherence and blood pressure control in persons living with HIV at 24 weeks.
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,363 Previous Clinical Trials
3,420,426 Total Patients Enrolled
Charles Muiruri, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
150 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion involves recruiting people from the Duke ID clinic, including HIV providers, clinic directors, nurses, pharmacists, social workers, people with HIV and hypertension, and community advisory board members, as well as other important individuals.You have severe hearing or speech impairment, are living in a nursing home or receiving in-patient psychiatric care, have a terminal illness with less than 4 months to live, lack reliable access to a telephone, are pregnant, breastfeeding, planning a pregnancy during the study, planning to move within the next 6 months, or do not speak English.I am over 18, HIV positive with undetectable viral load, have hypertension, take blood pressure medicine, and receive care at the Duke HIV clinic.Criterion: We are looking for healthcare providers who have been taking care of people living with HIV in the past 6 months.You are at least 18 years old, have HIV, receive care at the Duke ID clinic, have controlled HIV levels, take medication for high blood pressure, and have had high blood pressure on multiple occasions in the past year.
Research Study Groups:
This trial has the following groups:- Group 1: Aim 3B
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment stage of this experiment still open?
"According to the data available on clinicaltrials.gov, this medical trial is currently recruiting participants. It was first posted on August 1st 2022 and has had a recent update on August 4th 2022."
Answered by AI
How many participants have registered for this clinical trial?
"Affirmative. Clinicaltrials.gov confirms that the trial, first posted on August 1st 2022, is actively recruiting patients and seeks 60 participants from a single medical center."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger